Riskpilot← Back to searchSign inGet full accessDEXTRA ARTES AS
ASActiveOrg 941387403Øvre Slottsgate 3, 0157 OsloVisual arts creation activities · NACE 9012Est. 19860 employees
Revenue 2024
NOK 0
EBITDA margin
—
-46% vs 2023
Equity ratio
99.9%
Financial strength
Net profit 2024
NOK 353K
0 employees
| Revenue | NOK 0 | — |
| EBITDA | NOK -2,5M | -46% |
| Net profit | NOK 353K | — |
| Total assets | NOK 1,9B | +12% |
| Equity | NOK 1,9B | +12% |
| Employees | 0 | — |
Legal name
DEXTRA ARTES AS
Org number
941387403
Legal form
Aksjeselskap
NACE code
9012 · Visual arts creation activities
Founded
1. desember 1986
Share capital
NOK 2 055 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Selskapets formål er å videreføre en av sparebankenes tradisjonelle roller å være en bidragsyter for å øke den allmenne interessen for norsk og internasjonal billedkunst. Dextra artes as skal bl.a. Eie og aktivt forvalte en betydningsfull kunstsamling bestående av maleri, grafikk, foto og skulptur. Dextra artes as skal på ulike måter gjøre samlingen tilgjengelig for publikum, forskning og skole, samt bidra til økende kunnskap om billedkunst. Selskapet har ikke erverv som formål. Under selskapets formål hører enhver annen virksomhet som har tilknytning til forannevnte formål, herunder kjøp og salg av enkeltverker som ledd i vedlikehold eller utvikling av kunstsamlingen.
Address
Øvre Slottsgate 3, 0157 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 3 946 | 2 504 | 3 672 | 3 429 | 3 603 | 4 151 | 2 349 | 1 429 | 2 258 | 1 817 | 42 | 1 047 | 422 | 866 | 0 |
| Staff expenses | −0 | −0 | −0 | −247 | −278 | −331 | −373 | −363 | −331 | −355 | −325 | −326 | −325 | −326 | −326 | −325 | −325 | −325 |
| EBITDA | 0 | 0 | 0 | −277 | −772 | −383 | −420 | −752 | −351 | −115 | −446 | −539 | −800 | −331 | −663 | −1 495 | −1 736 | −2 541 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | 0 | 0 | −277 | −772 | −383 | −420 | −752 | −351 | −115 | −446 | −539 | −800 | −331 | −663 | −1 495 | −1 736 | −2 541 |
| Net financials | 0 | 0 | 0 | 277 | 772 | 383 | 420 | 752 | 351 | 115 | 446 | 539 | 800 | 331 | 663 | 1 495 | 1 736 | 2 894 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −0 | 0 | 0 | 0 | 0 | 0 | 353 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 353 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | — | — | 275 725 | 329 026 | 370 478 | 410 109 | 460 988 | 539 210 | 633 314 | 791 631 | 1 054 945 | 1 055 031 | 1 103 978 | 1 254 050 | 1 423 891 | 1 734 919 | 1 935 092 |
| Equity | — | — | — | 271 925 | 317 925 | 367 925 | 407 925 | 457 925 | 532 925 | 632 925 | 752 925 | 1 052 925 | 1 052 925 | 1 102 925 | 1 252 925 | 1 402 925 | 1 732 925 | 1 933 278 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 3 800 | 11 101 | 2 553 | 2 184 | 3 063 | 6 285 | 389 | 38 706 | 2 020 | 2 106 | 1 053 | 1 125 | 20 966 | 1 994 | 1 815 |
| Total debt | 0 | 0 | 0 | 3 800 | 11 101 | 2 553 | 2 184 | 3 063 | 6 285 | 389 | 38 706 | 2 020 | 2 106 | 1 053 | 1 125 | 20 966 | 1 994 | 1 815 |
EBITDA margin
-254141800.0%
This company
15.8%
Market median
-1608492505% vs market
20072024
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20072024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20072024
Net profit margin
35258900.0%
This company
8.1%
Market median
+435294962% vs market
20072024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20072024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20072024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AB Chief Executive Officer | Chief Executive Officer | 2008 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Deputy Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DEXTRA ARTES AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Bjørnsen | Chief Executive Officer | 0 companies |
| Susanna Kristina Pettersson | Board of Directors | 0 companies |
| Egil Matsen | Board of Directors | 0 companies |
| Silje Mariann Engja Sigurdsen | Board of Directors | 0 companies |
| Hanne Beate Ueland | Board of Directors | 0 companies |
| Kjetil Trædal Thorsen | Board of Directors | 0 companies |
| Sigurd Sverdrup Sandmo | Board of Directors | 0 companies |
| Anne Beate Hovind | Chairman | 0 companies |
| Ingrid Trøite Lorentzen | Board of Directors | 0 companies |
| Ottar Ertzeid | Deputy Chairman | 0 companies |
| Nils Messel | Board of Directors | 0 companies |